Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,440.00
-30.00 (-0.46%)
Last updated: Mar 25, 2025
-32.49%
Market Cap 71.48B
Revenue (ttm) 657.57B
Net Income (ttm) 63.04B
Shares Out 11.29M
EPS (ttm) 5,582.00
PE Ratio 1.13
Forward PE n/a
Dividend 100.00 (1.55%)
Ex-Dividend Date Dec 27, 2024
Volume 26,012
Average Volume 26,890
Open 6,410.00
Previous Close 6,470.00
Day's Range 6,110.00 - 6,600.00
52-Week Range 5,470.00 - 12,220.00
Beta 0.72
RSI 47.56
Earnings Date May 14, 2025

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 80
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.